Molecular and Functional Analysis of Tyrosinase-Related Protein (TRP)-2 as a Cytotoxic T Lymphocyte Target in Patients With Malignant Glioma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 • 2,196 citations
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 • 1,510 citations
A Phosphatase Associated with Metastasis of Colorectal Cancer
2001 • 641 citations
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
1999 • 578 citations
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
1996 • 542 citations
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
2001 • 501 citations
Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
1997 • 405 citations
High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
1999 • 388 citations
Brain tumor survival: results from the National Cancer Data Base.
1998 • 341 citations
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 • 307 citations
Human tumor antigens for cancer vaccine development
1999 • 298 citations
Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
1999 • 283 citations
Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
1996 • 272 citations
Coupling and Uncoupling of Tumor Immunity and Autoimmunity
1999 • 245 citations
Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigens
1999 • 239 citations
Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).
1998 • 199 citations
Regulation of mammalian melanogenesis I: partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase
1990 • 175 citations
Targeting of Lymphotoxin-α to the Tumor Elicits an Efficient Immune Response Associated with Induction of Peripheral Lymphoid-like Tissue
2001 • 172 citations
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
1997 • 154 citations
Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage
1998 • 141 citations
Anti-Tyrosinase-Related Protein-2 Immune Response in Vitiligo Patients and Melanoma Patients Receiving Active-Specific Immunotherapy
1998 • 134 citations
Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2
1994 • 117 citations
Genetic vaccination with 'self' tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
2000 • 116 citations
Expression of cancer testis genes in human brain tumors.
2000 • 116 citations
Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers.
1999 • 90 citations
HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients
1998 • 86 citations
Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy
2002 • 73 citations
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.
2001 • 69 citations
Use of an in Vitro Immunoselected Tumor Line to Identify Shared Melanoma Antigens Recognized by HLA-A*0201-restricted T Cells
2001 • 64 citations
Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications
2000 • 59 citations
Novel HLA-Cw8-Restricted T Cell Epitopes Derived from Tyrosinase-Related Protein-2 and gp100 Melanoma Antigens
1999 • 52 citations
EGFRvIII as a promising target for antibody-based brain tumor therapy
2000 • 52 citations
Identification of a new HLA-A*0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen
2000 • 49 citations
Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes
1997 • 39 citations
Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2
2000 • 39 citations
T cell-mediated immune responses in melanoma: implications for immunotherapy
2002 • 30 citations
Immunotherapy of malignant brain tumors in children and adults: from theoretical principles to clinical application
1999 • 22 citations
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responsesexvivo
2002 • 21 citations
Tyrosinase Protein Is Expressed Also in Some Neural Crest Derived Cells Which Are Not Melanocytes
1988 • 20 citations
Characterization of B16 melanoma-specific cytotoxic T lymphocytes
1998 • 19 citations
Human Melanocytes and Melanomas Express Novel mRNA Isoforms of the Tyrosinase-Related Protein-2/DOPAchrome Tautomerase Gene: Molecular and Functional Characterization
2000 • 17 citations
Cited By (0)
No citing papers found in database